Diagnosis, Treatment Response, and Prognosis: The Role of

3-Iodobenzylguanidine Adolescent Adult Aged Child Dihydroxyphenylalanine / analogs & derivatives Disease-Free Survival Female Humans Induction Chemotherapy Male Middle Aged Neuroblastoma / diagnostic imaging Positron Emission Tomography Computed Tomography / methods Prospective Studies Risk Young Adult
DOPA PET/CT chemotherapy neuroblastoma prognosis

Journal

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410

Informations de publication

Date de publication:
03 2020
Historique:
received: 18 06 2019
accepted: 12 08 2019
pubmed: 22 9 2019
medline: 29 9 2020
entrez: 22 9 2019
Statut: ppublish

Résumé

Our purpose was to evaluate the diagnostic role of

Identifiants

DOI: 10.2967/jnumed.119.232553 PMID: 31541036
pubmed: 31541036
pii: jnumed.119.232553
doi: 10.2967/jnumed.119.232553
doi:

Substances chimiques

fluorodopa F 18 2C598205QX
3-Iodobenzylguanidine 35MRW7B4AD
Dihydroxyphenylalanine 63-84-3

Types de publication

Clinical Trial Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

367-374

Informations de copyright

© 2020 by the Society of Nuclear Medicine and Molecular Imaging.

Auteurs

Arnoldo Piccardo (A)

Department of Nuclear Medicine, Galliera Hospital, Genoa, Italy arnoldo.piccardo@galliera.it.

Giovanni Morana (G)

Neuroradiology Unit, IRCCS Istituto Giannina Gaslini, Genova, Italy.

Matteo Puntoni (M)

Clinical Trial Research Unit, Galliera Hospital, Genoa, Italy.

Sara Campora (S)

Department of Oncology, Galliera Hospital, Genoa, Italy.

Stefania Sorrentino (S)

Unit of Pediatric Oncology, Istituto Giannina Gaslini, IRCCS, Genoa, Italy.

Pietro Zucchetta (P)

Department of Nuclear Medicine, University Hospital of Padova, Padova, Italy.

Martina Ugolini (M)

Medical Physics Department, Galliera Hospital, Genoa, Italy.

Massimo Conte (M)

Unit of Pediatric Oncology, Istituto Giannina Gaslini, IRCCS, Genoa, Italy.

Angelina Cistaro (A)

Department of Nuclear Medicine, Galliera Hospital, Genoa, Italy.

Giulia Ferrarazzo (G)

Department of Nuclear Medicine, Galliera Hospital, Genoa, Italy.

Marco Pescetto (M)

Anaesthesiology Department, Galliera Hospital, Genoa, Italy.

Marco Lattuada (M)

Anaesthesiology Department, Galliera Hospital, Genoa, Italy.

Gianluca Bottoni (G)

Department of Nuclear Medicine, Galliera Hospital, Genoa, Italy.

Alberto Garaventa (A)

Unit of Pediatric Oncology, Istituto Giannina Gaslini, IRCCS, Genoa, Italy.

Luca Giovanella (L)

Clinic of Nuclear Medicine and Molecular Imaging, Imaging Institute of Southern Switzerland, Bellinzona and Lugano, Switzerland; and.

Egesta Lopci (E)

Department of Nuclear Medicine, Humanitas Clinical and Research Hospital, IRCCS, Rozzano, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Composés chimiques organiques › Hydrocarbures › Hydrocarbures halogénés › Hydrocarbures iodés › Iodobenzènes › 3-Iodobenzyl-guanidine › Diagnosis, Treatment Response, and Prognosis:...
questionsmedicales.fr › Personnes › Tranches d'âge › Adolescent › Diagnosis, Treatment Response, and Prognosis:...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Diagnosis, Treatment Response, and Prognosis:...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › Diagnosis, Treatment Response, and Prognosis:...
questionsmedicales.fr › Personnes › Tranches d'âge › Enfant › Diagnosis, Treatment Response, and Prognosis:...
questionsmedicales.fr › Acides aminés, peptides et protéines › Acides aminés › Acides aminés cycliques › Acides aminés aromatiques › Tyrosine › Dopa › Diagnosis, Treatment Response, and Prognosis:...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Analyse de survie › Survie sans rechute › Diagnosis, Treatment Response, and Prognosis:...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Diagnosis, Treatment Response, and Prognosis:...
questionsmedicales.fr › Thérapeutique › Induction de rémission › Chimiothérapie d'induction › Diagnosis, Treatment Response, and Prognosis:...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Adulte d'âge moyen › Diagnosis, Treatment Response, and Prognosis:...
questionsmedicales.fr › Tumeurs › Tumeurs par type histologique › Tumeurs du tissu nerveux › Tumeurs neuroectodermiques › Tumeurs neuroépitheliales › Tumeurs neuroectodermiques primitives › Tumeurs neuroectodermiques primitives périphériques › Neuroblastome › Diagnosis, Treatment Response, and Prognosis:...
questionsmedicales.fr › Diagnostic › Techniques et procédures diagnostiques › Techniques de diagnostic radioisotopique › Scintigraphie › Tomoscintigraphie › Tomographie par émission de positons › Tomographie par émission de positons couplée à la tomodensitométrie › Diagnosis, Treatment Response, and Prognosis:...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études prospectives › Diagnosis, Treatment Response, and Prognosis:...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Risque › Diagnosis, Treatment Response, and Prognosis:...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Jeune adulte › Diagnosis, Treatment Response, and Prognosis:...